2018
Safety and Efficacy of Novel Oral Anticoagulants Versus Warfarin in Medicare Beneficiaries With Atrial Fibrillation and Valvular Heart Disease
Briasoulis A, Inampudi C, Akintoye E, Alvarez P, Panaich S, Vaughan‐Sarrazin M. Safety and Efficacy of Novel Oral Anticoagulants Versus Warfarin in Medicare Beneficiaries With Atrial Fibrillation and Valvular Heart Disease. Journal Of The American Heart Association 2018, 7: e008773. PMID: 29622591, PMCID: PMC6015407, DOI: 10.1161/jaha.118.008773.Peer-Reviewed Original ResearchConceptsValvular heart diseaseAtrial fibrillationMedicare beneficiariesIschemic strokeHeart diseaseNew-onset atrial fibrillationNon-vitamin K anticoagulantsGastrointestinal bleeding ratesLarge community-based samplePropensity-matched sampleCommunity-based sampleMajor bleedingNongastrointestinal bleedingCause mortalitySystemic thromboembolismVersus WarfarinPrimary outcomePropensity matchingMyocardial infarctionBleeding rateLower riskPatientsRivaroxabanWarfarinDabigatran
2017
Prevalence and predictors of intracranial aneurysms in patients with bicuspid aortic valve
Egbe A, Padang R, Brown R, Khan A, Luis S, Huston J, Akintoye E, Connolly H. Prevalence and predictors of intracranial aneurysms in patients with bicuspid aortic valve. Heart 2017, 103: 1508. PMID: 28596303, DOI: 10.1136/heartjnl-2016-311076.Peer-Reviewed Original ResearchMeSH KeywordsAge DistributionAgedAged, 80 and overAortic ValveBicuspid Aortic Valve DiseaseBrainEchocardiographyFemaleFollow-Up StudiesForecastingHeart Valve DiseasesHumansIntracranial AneurysmMagnetic Resonance AngiographyMaleMiddle AgedMinnesotaPrevalenceRetrospective StudiesRisk FactorsSex DistributionConceptsCoarctation of aortaBicuspid aortic valveLeft cusp fusionIntracranial aneurysmsCusp fusionAortic valveFemale genderBrain MR angiographyStudy mean ageAge tertilesRetrospective reviewCoil embolisationRisk factorsMayo ClinicHigh prevalenceAge 41General populationPatientsMR angiographyPrevalenceAneurysmsAgeRiskYearsEmbolisation